I
InMed Pharmaceuticals Inc. (INM)
NCM – Real vaqt narxi. Valyuta: USD
0.66
+0.03 (5.48%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.66
+0.03 (5.48%)
Yopilishda: May 12, 2026, 4:00 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.12 | 2.52 | 10 | |
| Tezkor likvidlik nisbati | 3.12 | 1.78 | 10 | |
| Qarz/Kapital nisbati | 0.06 | -0.80 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.05 | 0.73 | 9.0 | |
| Foiz to‘lov qoplami | N/A | -13.90 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 1M | 4M | 5M | 5M | 3M |
| Yalpi foyda | 68K | 1M | 496K | 1M | 584K |
| Operatsion daromad | -14M | -8M | -8M | -8M | -9M |
| Sof foyda | -19M | -8M | -8M | -8M | -9M |
| EBITDA | -13M | -8M | -8M | -7M | -8M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | N/A | 1.0 |
| Keyingi chorak | N/A | N/A | 1.0 |
| Joriy yil | N/A | N/A | 1.0 |
| Keyingi yil | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -99.99 | -46.24 | N/A | 25.2 | 3.3 |
| Yil/Yil | 999 | -39.85 | N/A | -12.62 | 3.3 |
| 3 yil o‘rtacha | 99.43 | 18.12 | 79.56 | 15.79 | 9.5 |
| 5 yil o‘rtacha | 459.26 | -8.4 | 45.87 | -8.83 | 5.5 |
| O‘rtacha ball | 5.4 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $5.2M umumiy qarzdan $420.1K sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $6.9M jami joriy majburiyatlardan $2.2M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.1) tarmoq o'rtachasidan (-0.8) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$1.8M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi